Targeting maspin in endothelial cells to induce cell apoptosis

Bibliography

• ZOU Z, ANISOWICZ A, HENDRIX MJ et al.: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (1994) 263(5146):526-529.
   PubMed Web of Science ®Google Scholar
• HENDRIX MJ: De-mystifying the mechanism(s) of maspin. Nat. Med. (2000) 6(4):374-376.
   PubMed Web of Science ®Google Scholar
• CHER ML, BILIRAN HR Jr, BHAGAT S et al.: Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc. Natl. Acad. Sci. USA (2003) 100(13):7847-7852.
   PubMed Web of Science ®Google Scholar
• MAASS N, HOJO T, ZHANG M, SAGER R, JONAT W, NAGASAKI K: Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol. (2000) 39(8):931-934.
   PubMedGoogle Scholar
• SHENG S, TRUONG B, FREDRICKSON D, WU R, PARDEE AB, SAGER R: Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc. Natl. Acad. Sci. USA (1998) 95(2):499-504.
   PubMedGoogle Scholar
• ZHANG M, SHENG S, MAASS N, SAGER R: mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility. Mol. Med. (1997) 3(1):49-59.
   PubMedGoogle Scholar
• BASS R, FERNANDEZ AM, ELLIS V: Maspin inhibits cell migration in the absence of protease inhibitory activity. J. Biol. Chem. (2002) 277(49):46845-46848.
   PubMedGoogle Scholar
• MAASS N, TEFFNER M, ROSEL F et al.: Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J. Pathol. (2001) 195(3):321-326.
   PubMedGoogle Scholar
• HOJO T, AKIYAMA Y, NAGASAKI K et al.: Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett. (2001) 171(1):103-110.
   PubMedGoogle Scholar
• SEFTOR RE, SEFTOR EA, SHENG S, PEMBERTON PA, SAGER R, HENDRIX MJ: maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. (1998) 58(24):5681-5685.
   PubMed Web of Science ®Google Scholar
• DOMANN FE, RICE JC, HENDRIX MJ, FUTSCHER BW: Epigenetic silencing of maspin gene expression in human breast cancers. Int. J. Cancer (2000) 85(6):805-810.
   PubMed Web of Science ®Google Scholar
• CAO D, WILENTZ RE, ABBRUZZESE JL, HO L, MAITRA A: Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int. J. Gastrointest. Cancer (2005) 36(1):39-46.
   PubMedGoogle Scholar
• TERASHIMA M, MAESAWA C, OYAMA K et al.: Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br. J. Cancer (2005) 92(6):1130-1136.
   PubMedGoogle Scholar
• ABRAHAM S, ZHANG W, GREENBERG N, ZHANG M: Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J. Urol. (2003) 169(3):1157-1161.
   PubMedGoogle Scholar
• BLACQUE OE, WORRALL DM: Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J. Biol. Chem. (2002) 277(13):10783-10788.
   PubMedGoogle Scholar
• NGAMKITIDECHAKUL C, WAREJCKA DJ, BURKE JM, O’BRIEN WJ, TWINING SS: Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J. Biol. Chem. (2003) 278(34):31796-806.
   PubMedGoogle Scholar
• ZHANG M, MAGIT D, BOTTERI F, SHI HY, HE K, LI M et al.: Maspin plays an important role in mammary gland development. Dev. Biol. (1999) 215(2):278-287.
   PubMedGoogle Scholar
• SHI HY, ZHANG W, LIANG R et al.: Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol. Histopathol. (2003) 18(1):201-206.
   PubMedGoogle Scholar
• ZHANG M, SHI Y, MAGIT D, FURTH PA, SAGER R: Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene (2000) 19(52):6053-6058.
   PubMed Web of Science ®Google Scholar
• SAGER R, SHENG S, PEMBERTON P, HENDRIX MJ: Maspin. A tumor suppressing serpin. Adv. Exp. Med. Biol. (1997) 425:77-88.
   PubMed Web of Science ®Google Scholar
• SHI HY, ZHANG W, LIANG R et al.: Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. (2001) 61(18):6945-6951.
   PubMedGoogle Scholar
• LI Z, SHI HY, ZHANG M: Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene (2005) 24(12):2008-2019.
   PubMed Web of Science ®Google Scholar
• SHI HY, LIANG R, TEMPLETON NS, ZHANG M: Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model. Mol. Ther. (2002) 5(6):755-761.
   PubMed Web of Science ®Google Scholar
• WATANABE M, NASU Y, KASHIWAKURA Y et al.: Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. Hum. Gene Ther. (2005) 16(6):699-710.
   PubMed Web of Science ®Google Scholar
• BOUDREAU N, MYERS C: Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Res. (2003) 5(3):140-146.
   PubMed Web of Science ®Google Scholar
• FOLKMAN J: Angiogenesis inhibitors generated by tumors. Mol. Med. (1995) 1(2):120-122.
   PubMed Web of Science ®Google Scholar
• FOLKMAN J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. (1995) 1(1):27-31.
   PubMed Web of Science ®Google Scholar
• HOOD JD, BEDNARSKI M, FRAUSTO R et al.: Tumor regression by targeted gene delivery to the neovasculature. Science (2002) 296(5577):2404-2407.
   PubMed Web of Science ®Google Scholar
• HOOD JD, CHERESH DA: Role of integrins in cell invasion and migration. Nat. Rev. Cancer (2002) 2(2):91-100.
   PubMed Web of Science ®Google Scholar
• HOOD JD, CHERESH DA: Targeted delivery of mutant Raf kinase to neovessels causes tumor regression. Cold Spring Harb. Symp. Quant. Biol. (2002) 67:285-291.
   PubMedGoogle Scholar
• KIM S, BELL K, MOUSA SA, VARNER JA: Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. (2000) 156(4):1345-1362.
   PubMed Web of Science ®Google Scholar
• KIM S, HARRIS M, VARNER JA: Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J. Biol. Chem. (2000) 275(43):33920-33928.
   PubMed Web of Science ®Google Scholar
• MAESHIMA Y, SUDHAKAR A, LIVELY JC et al.: Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science (2002) 295(5552):140-143.
   PubMed Web of Science ®Google Scholar
• O’REILLY MS, HOLMGREN L, SHING Y et al.: Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb. Symp. Quant. Biol. (1994) 59:471-482.
   PubMedGoogle Scholar
• O’REILLY MS, HOLMGREN L, SHING Y et al.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 79(2):315-328.
   PubMed Web of Science ®Google Scholar
• O’REILLY MS, WIEDERSCHAIN D, STETLER-STEVENSON WG, FOLKMAN J, MOSES MA: Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. (1999) 274(41):29568-29571.
   PubMed Web of Science ®Google Scholar
• PETITCLERC E, BOUTAUD A, PRESTAYKO A et al.: New functions for non-collagenous domains of human collagen Type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J. Biol. Chem. (2000) 275(11):8051-8061.
   PubMed Web of Science ®Google Scholar
• ZHANG M, VOLPERT O, SHI YH, BOUCK N: Maspin is an angiogenesis inhibitor. Nat. Med. (2000) 6(2):196-199.
   PubMed Web of Science ®Google Scholar
• SOLOMON LA, MUNKARAH AR, SCHIMP VL et al.: Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Gynecol. Oncol. (2006) Epub ahead of print.
   Google Scholar
• ZHANG W, SHI HY, ZHANG M: Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer (2005) 5(1):50.
   PubMed Web of Science ®Google Scholar
• LATHA K, ZHANG W, CELLA N, SHI HY, ZHANG M: Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell. Biol. (2005) 25(5):1737-1748.
   PubMed Web of Science ®Google Scholar
• SHI HY, LYDON JP, ZHANG M: Hormonal defect in maspin heterozygous mice reveals a role of progesterone in pubertal ductal development. Mol. Endocrinol. (2004) 18(9):2196-2207.
   PubMedGoogle Scholar
• GAO F, SHI HY, DAUGHTY C, CELLA N, ZHANG M: Maspin plays an essential role in early embryonic development. Development (2004) 131(7):1479-1489.
   PubMedGoogle Scholar